Hunan Nucien Pharmaceutical Co Ltd Class A 688189
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥6.39
- Day Range
- ¥6.49–7.29
- 52-Week Range
- ¥5.22–11.52
- Bid/Ask
- ¥7.23 / ¥7.25
- Market Cap
- ¥1.98 Bil
- Volume/Avg
- 13.0 Mil / 3.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.15
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 360
- Website
- http://www.nucien.com
Comparables
Valuation
|
Metric
|
688189
|
603896
|
300966
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 18.81 | 500.00 |
Price/Book Value | 1.34 | 2.05 | 1.94 |
Price/Sales | 4.15 | 5.76 | 3.61 |
Price/Cash Flow | 14.50 | 12.20 | 34.64 |
Price/Earnings
688189
603896
300966
Financial Strength
|
Metric
|
688189
|
603896
|
300966
|
|---|---|---|---|
Quick Ratio | 4.18 | 3.21 | 0.66 |
Current Ratio | 4.40 | 3.70 | 1.22 |
Interest Coverage | −2.93 | 16.62 | 0.47 |
Quick Ratio
688189
603896
300966
Profitability
|
Metric
|
688189
|
603896
|
300966
|
|---|---|---|---|
Return on Assets (Normalized) | −1.65% | 7.55% | 0.13% |
Return on Equity (Normalized) | −2.15% | 11.00% | 0.32% |
Return on Invested Capital (Normalized) | −1.82% | 7.10% | 0.69% |
Return on Assets
688189
603896
300966
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Sfhjkyyd | Gtfq | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Dsbvnzqbn | Zlcnwhd | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Szwsfrfqg | Tkmctn | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Wpqvzhrmj | Jnnmbdj | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Lmkyzmrzc | Fsmkd | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Rxvklvjx | Psp | $28.1 Bil | |||
| Moderna Inc
MRNA
| Xkwtrvrg | Bdgwr | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Czbyfflzd | Tytr | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Wmnfjgg | Njmryl | $13.4 Bil | |||
| Incyte Corp
INCY
| Zdpkrrng | Bczqvh | $12.7 Bil |
United States